FY2022 EPS Estimates for REGENXBIO Inc. Increased by SVB Leerink (NASDAQ:RGNX)
REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) – Equities research analysts at SVB Leerink upped their FY2022 earnings estimates for shares of REGENXBIO in a research note issued to investors on Tuesday, March 1st. SVB Leerink analyst M. Foroohar now forecasts that the biotechnology company will earn ($3.32) per share for the year, up from their […]